TipRanks
Go Ultimate55% OFF

Atrium Therapeutics, Inc. (RNA) Balance Sheet

Atrium Therapeutics, Inc. Balance Sheet

Atrium Therapeutics, Inc.'s total assets for Q2 2026 were $280.51M, a decrease of 4.05% from the previous quarter. RNA total liabilities were $65.94M for the fiscal quarter, a 13.18% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 278.35M$ 1.56B$ 628.55M$ 638.80M$ 427.58M
$ 71.07M$ 138.94M$ 127.79M$ 60.73M$ 46.15M
$ 207.29M$ 1.42B$ 500.76M$ 578.08M$ 381.43M

Currency in USD

Atrium Therapeutics, Inc. Debt to Assets

0600M1.2B1.8B0 %400 %800 %1200 %LiabilitiesDebt to Assets20182019202020212022202320242025AssetsLiabilitiesDebt to Assets